Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Clinical Evidence

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US.  They sought to determine whether targeted mild hypothermia is as effective as hypothermic machine perfusion (HMP) of kidneys obtained from brain dead donors. They compared the outcomes from kidney transplants of 1349 kidneys divided into 3 groups: hypothermia group (359 kidneys), hypothermic machine perfusion (511 kidneys), and a combination of both hypothermia and HMP (479 kidneys).  

Overall, they found that:  

  • Incidence of DGF was lower in the HMP group compared to the hypothermia group (19% vs. 30%) 
  • Odds ratios showed that the non-inferiority of hypothermia to HMP was not established (OR 1.56) 
  • One year graft survival was similar across all three groups.

They concluded that HMP was superior to hypothermia alone in reducing the incidence of delayed graft function, and that a combination of both therapies was not superior to HMP alone.

Read the full article here: www.nejm.org/doi/10.1056/NEJMoa2118265

Tagged In:

Clinical, DGF, Graft Survival, HMP, Kidney

The Latest

Check out the most recent posts

Katie, Strategic Account Manager

Katie, Strategic Account Manager

My connection to donation and transplantation began with my uncle’s heart transplant in 2002. Since 2011, I’ve served the field through roles in organ procurement, transplant nursing, service line leadership, and industry support for diagnostics and immunosuppressive...

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...